Effect of Tiotropium Bromide on Airway Inflammation and Programmed Cell Death 5 in a Mouse Model of Ovalbumin-Induced Allergic Asthma
出版年份 2019 全文链接
标题
Effect of Tiotropium Bromide on Airway Inflammation and Programmed Cell Death 5 in a Mouse Model of Ovalbumin-Induced Allergic Asthma
作者
关键词
-
出版物
Canadian Respiratory Journal
Volume 2019, Issue -, Pages 1-7
出版商
Hindawi Limited
发表日期
2019-10-02
DOI
10.1155/2019/6462171
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Future perspectives of anticholinergics for the treatment of asthma in adults and children
- (2019) Roland Buhl et al. Therapeutics and Clinical Risk Management
- Mometasone or Tiotropium in Mild Asthma with a Low Sputum Eosinophil Level
- (2019) Stephen C. Lazarus et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Muscarinic Antagonist Reduces Airway Inflammation and Bronchoconstriction Induced by Ambient Particulate Matter in a Mouse Model of Asthma
- (2018) Jun Kurai et al. International Journal of Environmental Research and Public Health
- Role of muscarinic antagonists in asthma therapy
- (2017) Mario Cazzola et al. Expert Review of Respiratory Medicine
- Expression of M3 acetylcholine receptor in asthmatic mice and bronchial airway remodeling prediction
- (2016) F. Zhao et al. GENETICS AND MOLECULAR RESEARCH
- Overexpression of programmed cell death 5 in a mouse model of ovalbumin-induced allergic asthma
- (2016) Xiaolin Diao et al. BMC Pulmonary Medicine
- PDCD5 Interacts with Tip60 and Functions as a Cooperator in Acetyltransferase Activity and DNA Damage-Induced Apoptosis
- (2015) Lanjun Xu et al. NEOPLASIA
- Is there a rationale and role for long-acting anticholinergic bronchodilators in asthma?
- (2014) David Price et al. npj Primary Care Respiratory Medicine
- SERUM PROGRAMMED CELL DEATH PROTEIN 5 (PDCD5) LEVELS IS UPREGULATED IN LIVER DISEASES
- (2013) Yingyu Chen et al. JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY
- Tiotropium bromide inhibits relapsing allergic asthma in BALB/c mice
- (2013) Berislav Bosnjak et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Effect of tiotropium bromide on airway remodeling in a chronic asthma model
- (2012) Ji Young Kang et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Role of M3 mAChR in in vivo and in vitro models of LPS-induced inflammatory response
- (2012) Zu-Peng Xu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- In vitro anticholinergic drugs affect CD8+ peripheral blood T-cells apoptosis in COPD
- (2011) Mirella Profita et al. IMMUNOBIOLOGY
- Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma
- (2011) Eric D. Bateman et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Effect of tiotropium bromide on airway inflammation and remodelling in a mouse model of asthma
- (2010) S. Ohta et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Tiotropium Bromide Step-Up Therapy for Adults with Uncontrolled Asthma
- (2010) Stephen P. Peters et al. NEW ENGLAND JOURNAL OF MEDICINE
- Additive role of tiotropium in severe asthmatics and Arg16Gly inADRB2as a potential marker to predict response
- (2009) H.-W. Park et al. ALLERGY
- Inhibition of neutrophil elastase-induced goblet cell metaplasia by tiotropium in mice
- (2009) N. Arai et al. EUROPEAN RESPIRATORY JOURNAL
- Smoke, Choline Acetyltransferase, Muscarinic Receptors, and Fibroblast Proliferation in Chronic Obstructive Pulmonary Disease
- (2009) M. Profita et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Alternative mechanisms for tiotropium
- (2009) E.D. Bateman et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Adenovirus-mediated PDCD5 gene transfer sensitizes K562 cells to apoptosis induced by idarubicin in vitro and in vivo
- (2008) Guo-Rui Ruan et al. APOPTOSIS
- Apoptosis, airway inflammation and anti-asthma therapy: From immunobiology to clinical application
- (2008) Fabrizio Spinozzi et al. PEDIATRIC ALLERGY AND IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More